Back to Search
JOEL MOSES, M.D.
M.D.
Infectious Disease Physician
NPI: 1477661205Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
185876-1(NY)
Research & Publications (20)
Clopidogrel bisulfate: in ST-segment elevation myocardial infarction: a viewpoint by Jeffrey W Moses.
PMID 17192132·Am J Cardiovasc Drugs·2006
4-observational
Do the beneficial effects of sirolimus-eluting stents extend beyond 1 year?
PMID 16186846·Nat Clin Pract Cardiovasc Med·2005
8-other
Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.
PMID 18804877·Int J Cardiol·2010
4-observational
G-quadruplex compounds and cis-platin act synergistically to inhibit cancer cell growth in vitro and in vivo.
PMID 19475728·Biochem Pharmacol·2009
4-observational
Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention.
PMID 19526385·Acute Card Care·2009
4-observational
Highly stable ultrabroadband mid-IR optical parametric chirped-pulse amplifier optimized for superfluorescence suppression.
PMID 19488133·Opt Lett·2009
8-other
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.
PMID 19351691·Eur Heart J·2009
2-rct
A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis.
PMID 19463466·JACC Cardiovasc Interv·2009
4-observational
In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study.
PMID 19608137·JACC Cardiovasc Imaging·2009
3-trial
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
PMID 19463408·JACC Cardiovasc Interv·2009
4-observational
Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis.
PMID 19406344·J Am Coll Cardiol·2009
1-meta
Impact of myocardial bridge on clinical outcome after coronary stent placement.
PMID 19427426·Am J Cardiol·2009
8-other
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
PMID 19460609·J Am Coll Cardiol·2009
4-observational
Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.
PMID 19389558·J Am Coll Cardiol·2009
4-observational
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.
PMID 19528338·Circulation·2009
4-observational
Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
PMID 19539252·JACC Cardiovasc Interv·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1164 ROSEHILL BLVD
SCHENECTADY, NY 12309 - Phone
- (518) 421-2255
Quick Facts
- NPI
- 1477661205
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile